Digital Ally, Inc Announces First Quarter 2022 Operating Results

The following excerpt is from the company's SEC filing.
Quarter 2022 Revenues Improve 306% Compared to 2021
Kansas (May 20, 2022)
– Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”), today announced its operating
results for the first quarter of 2022. An investor conference call is scheduled for 11:15 a.m. EDT on Tuesday, May 24, 2022 (see details
for the first quarter ended March 31, 2022
revenues increased in the first quarter 2022 to $10,294,781 from $2,535,829 in the first quarter 2021 an improvement of $7,758,952
(306.0%). The primary reason for the overall revenue increase is an increase of $7,261,469 (1165.1%), in service revenues from 2021
primarily due to revenues generated by the Company’s recent acquisitions and increased service revenues from the
Company’s legacy business. The restoration of public events has begun, although slower than anticipated, thus adversely
affecting our installation and situational security revenues. Lastly, the Company’s subscription plan model continues to gain
traction in the marketplace, resulting in the Company building and recognizing its recurring revenues.
September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC (“Goody Tickets”) and TicketSmarter, LLC
(“TicketSmarter”) (collectively the “TicketSmarter Acquisition”). Goody Tickets and TicketSmarter
are ticket resale marketplaces with seats offered at over 125,000 live events, offering over 48 million tickets for sale through
its platform. This acquisition generated additional revenues for the period totaling $6,380,775 in service and
product revenues. TicketSmarter revenues are seasonal with the first quarter of the year generally constrained by the ending of
college and professional football events and weather conditions for the start of baseball season. This was especially true this year
as Major League Baseball experienced a work stoppage which reduced spring training schedules and delayed the opening of the regular
season. The Company expects to see further increases in revenues for the remainder of 2022 and beyond attributable to
TicketSmarter. The Company is also seeking additional acquisitions that would complement our TicketSmarter Acquisition, although
there can be no assurance that we will be successful in that regard.
have recently entered the revenue cycle management business late in the second quarter of
2021 with the formation of our wholly owned subsidiary, Digital Ally Healthcare, Inc. and
its majority-owned subsidiary Nobility Healthcare, LLC (“Nobility Healthcare”).
Nobility Healthcare completed its first acquisition on June 30, 2021, when it acquired a
private medical billing company, and a second acquisition on August 31, 2021 upon the completion
of its acquisition of another private medical billing company.

On January 1, 2022, the Nobility Healthcare completed the acquisition of 100% of the
capital stock of a private dental billing company. Additionally, on February 1, 2022, Nobility
Healthcare also completed an asset purchase for a portfolio of a medical billing company.
These acquisitions further enhanced the Company’s revenue cycle management operating
segment, which provides leading-edge revenue cycle management solutions to medium to
large healthcare organizations throughout the country. These acquisitions, along with the
revenue cycle management operating segment’s acquisitions that were previously
completed in 2021, generated service revenues of $1,903,957 during
the three months ended March 31, 2022. The Company expects to see further increases in revenues
for 2022 and beyond attributable to Nobility Healthcare.
revenue cycle management operating segment is following a roll-up strategy in the medical billing industry. The venture’s
acquisition targets include the approximate 6,000 medical billing companies in the United States, most of which are relatively small
and closely-held private companies. Each year a portion of these company owners sell because they want to retire or exit the business
for other pursuits. The medical billing market is quite fragmented with the largest companies having less than an estimated 5% of
the total market. The Company saw the opportunity to form the venture and provide the capital to make acquisitions and pursue the
medical billing company roll-up strategy at a faster pace. We expect our revenue cycle management operating segment to continue
its track record of providing superior medical billing services and practice management services, as well as executing a profitable
roll-up strategy.
gross profit for the three months ended March 31, 2022 and 2021 was $1,939,619 and $811,882, respectively, an increase of $1,127,737
(138.9%). The overall increase is attributable to the large overall increase in revenues for the three months ended March 31,
2022 and an increase in the overall cost of sales as a percentage of overall revenues to 81.1% for the three months ended March 31,
2022 from 68.0% for the three months ended March 31, 2021. Our goal is to improve our margins over the longer term based on the expected
margins generated by our new revenue cycle management and ticketing operating segments together with our video solutions operating
segment and its expected margins from our EVO-HD, DVM-800, VuLink, FirstVu Pro, FirstVu II, FirstVu HD, ThermoVu
, Shield

disinfectants and our cloud evidence storage and management offering, provided that they gain traction in the marketplace and
subject to a normalizing economy in the wake of the COVID-19 pandemic. In addition, if revenues from the video solutions segment
increase, we will seek to further improve our margins from this segment through expansion and increased efficiency utilizing fixed
manufacturing overhead components. We plan to continue our initiative to more efficient management of our supply chain through outsourcing
production, quantity purchases and more effective purchasing practices.
general and administrative expense totaled $8,742,957 and $3,677,575 for the three months ended March 31, 2022 and 2021, respectively,
an increase of $5,065,382 (137.7%). The increase was primarily attributable to the recent TicketSmarter and medical billing company
acquisitions that were not applicable to the three months ended March 31, 2021.

2021, the Company issued detachable warrants to purchase a total of 42,550,000 shares of Common Stock in association with the two
registered direct offerings that were completed which raised total funds of approximately $66.6 million. The underlying warrant
agreement terms provide for net cash settlement outside the control of the Company in the event of tender offers under certain circumstances.
As such, the Company was required to treat these warrants as derivative liabilities which are valued at their estimated fair value
as of their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations
as the change in fair value of warrant derivative liabilities. The change in fair value for the three months ended March
31, 2022 totaled $148,171 which was recognized as a gain for the three months ended March 31, 2022 as compared to a gain of $24,552,257
during the three months ended March 31, 2021.
December 6, 2021, the Board of Directors of the Company authorized the repurchase of up to $10.0 million of the Company’s outstanding
common stock under the specified terms of a share repurchase program (the “Program”). Subsequent to March 31, 2022, the
Company repurchased 1,280,387 shares of its common stock for $1,415,382, in accordance with the Program. The Program
does not obligate the Company to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or
open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Since the adoption of this Program, the Company has repurchased a total of 4,890,421 shares of its common stock.
Stanton E. Ross, Chief Executive Officer of Digital
Ally, stated, “We are very pleased to report a 306% increase in total revenues for the first quarter of 2022 as compared to the
first quarter of 2021. Importantly, we were able to report dramatic improvements in revenue and gross profit through our recent accretive
acquisitions beginning in late June of 2021 and continuing through the first quarter of 2022. We are very excited about the market’s
recent reaction and level of interest in our recent product announcements within our legacy product lines, consisting of our FirstVu
Pro, FirstVu II, and QuickVu docking stations, which are already gaining traction throughout the marketplace, particularly when paired
with our subscription plan offerings. We continue to build enthusiasm around the momentum being gained in our revenue cycle management
operating segment, as Nobility Healthcare, LLC continues to complete acquisitions through the first quarter of 2022. Specifically,
in our revenue cycle management operating segment, we completed one business acquisition in January 2022 along with an asset purchase
in February 2022, with a continued pursuit of other acquisitions to complete throughout the remainder of 2022. The numerous acquisitions
we have already completed of medical billing companies demonstrates that our roll-up strategy is effective and attractive to potential
targets. We look forward to seeing the growth potential of this revenue cycle management operating segment come to fruition and
continue throughout 2022 and beyond.”
added: “Additionally, we continue to be thrilled with the addition of TicketSmarter to our growing holdings of solid revenues and
growth-potential businesses, as the TicketSmarter Acquisition proved to be accretive to revenues in the first three months of
2022. TicketSmarter generated nearly $6.4 million in revenue over that span, representing almost 62% of the Company’s overall
revenues in the first quarter of 2022. TicketSmarter was able to add three very exciting partners to its vast partnership
network – Gannett Media/USA Today, Sinclair Broadcast Group and iHeart Media. We are excited to see a full year of
results of our operation with these new acquisitions and the exciting opportunities and synergies we can utilize throughout the Company.
We believe shareholders will benefit from TicketSmarter’s long-term value based on the attractive price the Company paid, in comparison
to the multiples commanded by similar public companies. We continue to have substantial liquid resources available to us that will enable
us to pursue organic expansion of our legacy business as well as potential acquisitions. As discussed, we have already put these resources
to work and plan to continue pursuing and reviewing several opportunities; however, we are proceeding cautiously given the current environment
and future uncertainties. We will inform our investors as we attempt to take advantage of new business opportunities and to expand our
existing business lines to benefit the Company and its shareholders for the remainder of 2022 and beyond.”
Operating Results
the three months ended March 31, 2022, our total revenue increased by 306% to approximately $10.3 million, compared with revenue of approximately
$2.5 million for the three months ended March 31, 2021.
profit increased 138.9% to $1,939,619 for the three months ended March 31, 2022 versus $811,882 for the three months ended March 31,
2021. The overall increase is attributable to the 306% overall increase in revenues for the three months ended March 31, 2022, partially
offset by an increase in the overall cost of sales as a percentage of overall revenues to 81.2% for the three months ended March
31, 2022 from 68.0% for the three months ended March 31, 2021.
general and administrative expenses increased approximately 138% to $8,742,957 in the three months
ended March 31, 2022 versus $3,677,575 in 2021. The increase was primarily attributable to the recent acquisitions completed in 2021
and first quarter 2022. Our selling, general and administrative expenses as a percentage of sales decreased to 85% for the first quarter
2022 compared to 145% in the same period in 2021.
reported an operating loss of ($6,803,338) for the three months ended March 31, 2022, compared to an operating loss of ($2,865,693) in
the same period of 2021.
other income decreased to $105,096 for the three months ended March 31, 2022, compared to total other income of $24,587,551 in
the same period 2021. The decrease in other income was attributable to the $148,171 change in fair value of warrant derivative liabilities
reported in the first quarter 2022, compared to the $24,552,257 change in the same period of 2021. The change in fair value of warrant
derivative liabilities was related to reductions in the value of the detachable common stock purchase warrants issued in conjunction
with the two registered direct offerings we completed in 2021.
reported net loss attributable to common stockholders of ($6,600,148), or ($0.13) per share, in the three months ended March 31, 2022
compared to $21,721,859, or $0.49 per share, in the same period in 2021. No income tax provision or benefit was recorded in the
either first quarter 2022 or 2021 as the Company has maintained a full valuation reserve on its deferred tax assets.
Conference Call
Company will host an investor conference call at 11:15 a.m. EDT on Tuesday May 24, 2022, to discuss its operating results for the first
quarter of 2022, developments related to its three operating segments, which includes the Company’s recent acquisitions, and other
topics of interest. Shareholders and other interested parties may participate in the conference call by dialing 844-761-0863 and entering
conference ID #8977727 a few minutes before 11:15 a.m. EDT on Tuesday May 24, 2022.
replay of the conference call will be available two hours after its completion, from May 24, 2022 until 11:59 p.m. on July 24, 2022 through
our company website
additional news and
information please visit

or follow additional Digital Ally Inc. social media channels here:

press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Act of 1934, as amended. These forward-looking statements are based largely on the expectations
or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown
uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking
statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking
statements include, but are not limited to, the following: (1) our losses in recent years, including during fiscal 2020 and 2019;
(2) economic and other risks for our business from the effects of the COVID-19 pandemic, including the impacts on our law-enforcement
and commercial customers, suppliers and employees and on our ability to raise capital as required; (3) our ability to increase revenues,
increase our margins and return to consistent profitability in the current economic and competitive environment; (4) our operation in
developing markets and uncertainty as to market acceptance of our technology and new products; (5) the availability of funding from federal,
state and local governments to facilitate the budgets of law enforcement agencies, including the timing, amount and restrictions on such
funding; (6) our ability to deliver our new product offerings, such as the Shield™ disinfectant/sanitizers products and ThermoVU™ temperature
screening systems, whether such new products perform as planned or advertised and whether they will help increase our revenues, particularly
as the COVID-19 pandemic begins to subside; (7) whether we will be able to increase the sales, domestically and internationally, for
our products in the future; (8) our ability to maintain or expand our share of the market for our products in the domestic and international
markets in which we compete, including increasing our international revenues; (9) our ability to produce our products in a cost-effective
manner; (10) competition from larger, more established companies with far greater economic and human resources; (11) our ability to attract
and retain quality employees; (12) risks related to dealing with governmental entities as customers; (13) our expenditure of significant
resources in anticipation of sales due to our lengthy sales cycle and the potential to receive no revenue in return; (14) characterization
of our market by new products and rapid technological change; (15) our dependence on sales of our EVO-HD, DVM-800, DVM-250 and FirstVU
products; (16) that stockholders may lose all or part of their investment if we are unable to compete in our markets and return to profitability;
(17) defects in our products that could impair our ability to sell our products or could result in litigation and other significant costs;
(18) our dependence on key personnel; (19) our reliance on third-party distributors and sales representatives for part of our marketing
capability; (20) our dependence on a few manufacturers and suppliers for components of our products and our dependence on domestic and
foreign manufacturers for certain of our products; (21) our ability to protect technology through patents and to protect our proprietary
technology and information, such as trade secrets, through other similar means; (22) our ability to generate more recurring cloud and
service revenues; (23) risks related to our license arrangements; (24) the fluctuation of our operation results from quarter to quarter;
(25) sufficient voting power by coalitions of a few of our larger stockholders, including directors and officers, to make corporate governance
decisions that could have a significant effect on us and the other stockholders; (26) the issuance or sale of substantial amounts of
our common stock, or the perception that such sales may occur in the future, which may have a depressive effect on the market price of
our securities; (27) potential dilution from the issuance of common stock underlying outstanding options and warrants; (28) our additional
securities available for issuance, which, if issued, could adversely affect the rights of the holders of our common stock; (29) the volatility
of our stock price due to a number of factors, including, but not limited to, a relatively limited public float; and (30) our ability
to integrate and realize the anticipated benefits from acquisitions These cautionary statements should not be construed as exhaustive
or as any admission as to the adequacy of the Company’s disclosures. The Company cannot predict or determine after the fact what
factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The
reader should consider statements that include the words “believes,” “expects,” “anticipates,” “intends,”
“estimates,” “plans,” “projects,” “should,” or other expressions that are predictions
of or indicate future events or trends, to be uncertain and forward-looking. It does not undertake to publicly update or revise forward-looking
statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially
affect the Company and its operations are contained in its Quarterly Report on Form 10-Q for the three months ended March 31,
2022 and in its Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
Additional Information, Please Contact:
E. Ross, CEO, at (913) 814-7774 or
J. Heckman, CFO, at (913) 814-7774
Highlights Follow)
31, 2022 AND DECEMBER 31, 2021
March 31, 2022 (Unaudited)
Current assets:
Cash and cash equivalents
Accounts receivable – trade, net
Other receivables (including $158,384 due from related parties – March 31, 2022 and $158,384 – December 31, 2021, refer to Note 19)
Inventories, net
Prepaid expenses
Total current assets
Property, plant, and equipment, net
Goodwill and other intangible assets, net
Operating lease right of use assets, net
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses
Current portion of operating lease obligations
Contract liabilities – current portion
Debt obligations – current portion
Warrant derivative liabilities
Income taxes payable
Total current liabilities
Long-term liabilities:
Debt obligations – long term
Operating lease obligation – long term
Contract liabilities – long term
Total liabilities
Commitments and contingencies
Stockholders’ Equity:
Common stock, $0.001 par value per share; 100,000,000 shares authorized; shares issued: 49,728,357 shares issued – March 31, 2022 and 50,904,391 shares issued – December 31, 2021
Additional paid in capital
Noncontrolling interest in consolidated subsidiary
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
31, 2022 AND 2021
Three months ended
Service and other
Total revenue
Cost of revenue:
Total cost of revenue
Gross profit
Selling, general and administrative expenses:
Research and development expense
Selling, advertising and promotional expense
General and administrative expense
Total selling, general and administrative expenses
Operating loss
Other income (expense):
Interest income
Interest expense
Change in fair value of contingent consideration promissory notes
Change in fair value of short-term investments
Change in fair value of warrant derivative liabilities
Total other income
Income (loss) before income tax benefit
Income tax benefit
Net income (loss)
Net loss attributable to noncontrolling interests of consolidated subsidiary
Net income (loss) attributable to common stockholders
Net income (loss) per share information:
Weighted average shares outstanding:

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Digital Ally makes a similar move, sign up!

Other recent filings from the company include the following:

Digital Ally Just Filed Its Quarterly Report: NOTE 16. NET EARNING... - Aug. 15, 2022

Auto Refresh